The Quadrivalent Approach to Influenza Vaccination

Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults

(2013) Jiří Beran et al.   BMC INFECTIOUS DISEASES

Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine Candidate: A Phase III Randomized Controlled Trial in Children

(2013) Joanne M. Langley et al.   JOURNAL OF INFECTIOUS DISEASES

A Randomized Trial of Candidate Inactivated Quadrivalent Influenza Vaccine versus Trivalent Influenza Vaccines in Children Aged 3–17 Years

(2013) Joseph B. Domachowske et al.   JOURNAL OF INFECTIOUS DISEASES

Quadrivalent Ann Arbor strain live-attenuated influenza vaccine

(2012) Seth L Toback et al.   Expert Review of Vaccines

Immunogenicity and Safety of a Quadrivalent Live Attenuated Influenza Vaccine in Children

(2012) Stan L. Block et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

The economic value of a quadrivalent versus trivalent influenza vaccine

(2012) Bruce Y. Lee et al.   VACCINE

Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine

(2012) Carrie Reed et al.   VACCINE

Safety and immunogenicity of a quadrivalent inactivated influenza vaccine compared to licensed trivalent inactivated influenza vaccines in adults

(2012) David P. Greenberg et al.   VACCINE

Clinical manifestations and socio-economic impact of influenza among healthy children in the community

(2011) Susanna Esposito et al.   JOURNAL OF INFECTION

A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults

(2011) Stan L. Block et al.   VACCINE